Gerard Schellenberg

1.6k total citations
23 papers, 811 citations indexed

About

Gerard Schellenberg is a scholar working on Genetics, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Gerard Schellenberg has authored 23 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 4 papers in Clinical Biochemistry and 3 papers in Molecular Biology. Recurrent topics in Gerard Schellenberg's work include Genetic Associations and Epidemiology (5 papers), Genetics and Neurodevelopmental Disorders (4 papers) and Alzheimer's disease research and treatments (3 papers). Gerard Schellenberg is often cited by papers focused on Genetic Associations and Epidemiology (5 papers), Genetics and Neurodevelopmental Disorders (4 papers) and Alzheimer's disease research and treatments (3 papers). Gerard Schellenberg collaborates with scholars based in United States, Germany and Vietnam. Gerard Schellenberg's co-authors include Gail P. Jarvik, Clement E. Furlong, Laura S. Rozek, Rebecca J. Richter, Victoria H. Brophy, Thomas S. Hatsukami, Ellen M. Wijsman, Géraldine Dawson, Annette Estes and Ronald G. Gregg and has published in prestigious journals such as Neurology, The American Journal of Human Genetics and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Gerard Schellenberg

21 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerard Schellenberg United States 11 323 174 171 155 141 23 811
Carmen Martínez Spain 17 64 0.2× 33 0.2× 268 1.6× 82 0.5× 85 0.6× 34 879
Maneesh Gupta United States 17 245 0.8× 50 0.3× 385 2.3× 52 0.3× 33 0.2× 34 903
Małgorzata Bednarska‐Makaruk Poland 14 100 0.3× 28 0.2× 114 0.7× 31 0.2× 72 0.5× 50 583
Bluma Tischler Canada 14 200 0.6× 33 0.2× 217 1.3× 175 1.1× 80 0.6× 31 625
Seong‐Su Nah South Korea 17 83 0.3× 9 0.1× 153 0.9× 40 0.3× 120 0.9× 33 716
Roberto Colombo Italy 16 26 0.1× 28 0.2× 315 1.8× 154 1.0× 121 0.9× 35 981
Manuela Grazina Portugal 15 164 0.5× 11 0.1× 443 2.6× 232 1.5× 27 0.2× 45 847
Michael Schmolke Germany 19 43 0.1× 595 3.4× 235 1.4× 114 0.7× 32 0.2× 72 1.1k
Yuan Qu China 17 11 0.0× 24 0.1× 263 1.5× 48 0.3× 86 0.6× 34 728
Natsuko Tokonami Switzerland 13 62 0.2× 20 0.1× 371 2.2× 70 0.5× 18 0.1× 16 929

Countries citing papers authored by Gerard Schellenberg

Since Specialization
Citations

This map shows the geographic impact of Gerard Schellenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard Schellenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard Schellenberg more than expected).

Fields of papers citing papers by Gerard Schellenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerard Schellenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard Schellenberg. The network helps show where Gerard Schellenberg may publish in the future.

Co-authorship network of co-authors of Gerard Schellenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Gerard Schellenberg. A scholar is included among the top collaborators of Gerard Schellenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerard Schellenberg. Gerard Schellenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burton, Elizabeth A., Chun-Hung Su, Elisabetta Manduchi, et al.. (2024). Variant‐to‐function mapping of late‐onset Alzheimer’s disease GWAS loci in human microglial models implicates RTFDC1 as an effector gene at the CASS4 locus. Alzheimer s & Dementia. 20(S1). e089683–e089683.
2.
Tong, Tong, Congcong Zhu, John J. Farrell, et al.. (2024). Blood-derived mitochondrial DNA copy number is associated with Alzheimer disease, Alzheimer-related biomarkers and serum metabolites. Alzheimer s Research & Therapy. 16(1). 234–234. 9 indexed citations
3.
Patel, Devanshi, Jaeyoon Chung, Jesse Mez, et al.. (2018). O5‐04‐02: RARE CODING MUTATIONS ASSOCIATED WITH ALZHEIMER DISEASE AND OTHER DEMENTIAS. Alzheimer s & Dementia. 14(7S_Part_31). 1 indexed citations
4.
Zhang, Xiaoling, Congcong Zhu, Gary W. Beecham, et al.. (2018). A rare missense variant of CASP7 is associated with familial late‐onset Alzheimer's disease. Alzheimer s & Dementia. 15(3). 441–452. 30 indexed citations
5.
Guarino, Peter, Julia E. Vertrees, Sanjay Asthana, et al.. (2016). Measuring informed consent capacity in an Alzheimer's disease clinical trial. Alzheimer s & Dementia Translational Research & Clinical Interventions. 2(4). 258–266. 10 indexed citations
6.
Reitz, Christiane, Brian W. Kunkle, Badri N. Vardarajan, et al.. (2014). Whole-Exome Sequencing Of Hispanic Early-Onset Alzheimer Disease Families Identifies Rare Variants In Multiple Alzheimer-Related Genes (S28.003). Neurology. 82(10_supplement). 1 indexed citations
7.
Kohli, Martin, Brian W. Kunkle, Adam C. Naj, et al.. (2013). O3–01–04: The identification of rare variants in late‐onset Alzheimer's disease using extended families. Alzheimer s & Dementia. 9(4S_Part_13). 1 indexed citations
8.
Naj, Adam C., Carlos Cruchaga, Brian W. Kunkle, et al.. (2013). O3–01–02: Exome array analysis identifies novel risk variants for non‐familial early‐onset Alzheimer's disease. Alzheimer s & Dementia. 9(4S_Part_13). 1 indexed citations
9.
Gilman, Sid, et al.. (2012). P3‐016: ER stress in Alzheimer's disease and PSP: Common disease mechanism?. Alzheimer s & Dementia. 8(4S_Part_12). 1 indexed citations
10.
Naj, Adam C., Gyungah Jun, Paul J. Gallins, et al.. (2011). P1‐250: Genome‐Wide Association Study of Late‐Onset Alzheimer Disease Identifies Disease‐Associated Variants in MS4A4/MS4A6E, CD2AP, CD33, and EPHA1. Alzheimer s & Dementia. 7(4S_Part_6). 27 indexed citations
11.
Chapman, Nicola H., Annette Estes, Jeff Munson, et al.. (2010). Genome-scan for IQ discrepancy in autism: evidence for loci on chromosomes 10 and 16. Human Genetics. 129(1). 59–70. 39 indexed citations
12.
Schellenberg, Gerard, Géraldine Dawson, Yun Ju Sung, et al.. (2006). Evidence for genetic linkage of autism to chromosomes 7 and 4. Molecular Psychiatry. 11(11). 979–979. 2 indexed citations
13.
Rozek, Laura S., Thomas S. Hatsukami, Rebecca J. Richter, et al.. (2005). The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status. Journal of Lipid Research. 46(9). 1888–1895. 46 indexed citations
14.
Sung, Yun Ju, Géraldine Dawson, Jeffrey Munson, et al.. (2004). Genetic Investigation of Quantitative Traits Related to Autism: Use of Multivariate Polygenic Models with Ascertainment Adjustment. The American Journal of Human Genetics. 76(1). 68–81. 87 indexed citations
15.
Tsuang, Debby W., Andrew D. Skol, Stephen V. Faraone, et al.. (2001). Examination of genetic linkage of chromosome 15 to schizophrenia in a large Veterans Affairs Cooperative Study sample. American Journal of Medical Genetics. 105(8). 662–668. 2 indexed citations
16.
Brophy, Victoria H., Gail P. Jarvik, Rebecca J. Richter, et al.. (2000). Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype. Pharmacogenetics. 10(5). 453–460. 50 indexed citations
17.
Jarvik, Gail P., Laura S. Rozek, Victoria H. Brophy, et al.. (2000). Paraoxonase (PON1) Phenotype Is a Better Predictor of Vascular Disease Than Is PON1 192 or PON1 55 Genotype. Arteriosclerosis Thrombosis and Vascular Biology. 20(11). 2441–2447. 259 indexed citations
18.
Fishel, Mark A., Debby W. Tsuang, Murray A. Raskind, et al.. (2000). Lewy body pathology in familial (presenilin-2) Alzheimer's disease. Neurobiology of Aging. 21. 66–66. 1 indexed citations
19.
Schellenberg, Gerard. (1995). Progress in Alzheimerʼs disease genetics. Current Opinion in Neurology. 8(4). 262–267. 20 indexed citations
20.
Schellenberg, Gerard, M. A. Pericak‐Vance, Ellen M. Wijsman, et al.. (1991). Linkage analysis of familial Alzheimer disease, using chromosome 21 markers.. PubMed. 48(3). 563–83. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmen Martínez Breakdown of academic impact, for papers by Maneesh Gupta Breakdown of academic impact, for papers by Małgorzata Bednarska‐Makaruk Breakdown of academic impact, for papers by Bluma Tischler Breakdown of academic impact, for papers by Seong‐Su Nah Breakdown of academic impact, for papers by Roberto Colombo Breakdown of academic impact, for papers by Manuela Grazina Breakdown of academic impact, for papers by Michael Schmolke Breakdown of academic impact, for papers by Yuan Qu Breakdown of academic impact, for papers by Natsuko Tokonami
Rankless by CCL
2026